会议材料

EAHAD 2025 - 欧洲血友病及相关疾病协会年会 2025
18th Annual Congress of the European Association for Haemophilia and Allied Disorders
-
意大利 · 米兰

本内容仅供您个人及教育用途。请勿下载或进一步传播。未经版权所有者许可,不得进一步复制或传播

共8条结果
会议壁报
Patient Burden and Preferences for Hemophilia Treatments: A Multi-Country Discrete-Choice Experiment with Hemo-TEM
Lu H, Whitty J, Colavecchia C, Gould T, Coulter J, Wilcox LJ, Cappelleri JC, Christopher SA, Sohn A, Hauber B, Dunn N, Chowdary P
EAHAD 2025 - 欧洲血友病及相关疾病协会年会 2025 | 罕见病 | 血友病
会议壁报
A Real World Study of Haemophilia Treatment Satisfaction, Bleeds, Health Related Quality of Life as Reported by Patients and Physicians to Demonstrate Gaps
Thakkar S, Merla V, Wilcox L, Sohn A, Sahar R, Blazos C, Lai S, Morton E, Wynne-Cattanach K, Ball N
EAHAD 2025 - 欧洲血友病及相关疾病协会年会 2025 | 罕见病 | 血友病
口头报告
Outcomes by Dose Escalation Criteria in Participants With Hemophilia A or B Without Inhibitors Receiving Marstacimab in the BASIS Trial
Frenzel L, Gould T, Sun P, Palladino A
EAHAD 2025 - 欧洲血友病及相关疾病协会年会 2025 | 罕见病 | 血友病 | 友瑞宁
会议壁报
Health-Related Quality of Life Outcomes for Marstacimab in Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B Without Inhibitors: Results From the Phase 3 BASIS Trial
Jiménez-Yuste V, Mazar I, Khanji C, Cappelleri JC, Bushmakin AG, Palladino, A, McDonald R, Hwang E, Taylor CT, Teeter J
EAHAD 2025 - 欧洲血友病及相关疾病协会年会 2025 | 罕见病 | 血友病 | 友瑞宁
会议壁报
Surgical and Medical Procedures in Participants With Hemophilia A or B Without Inhibitors Receiving Marstacimab in the BASIS and Open-Label Extension Trials
Benitez O, Kim HK, Taylor CT, McDonald R, McComb B,  Sun P, Palladino A
EAHAD 2025 - 欧洲血友病及相关疾病协会年会 2025 | 罕见病 | 血友病 | 友瑞宁
会议壁报
Exogenous Factor Consumption in Participants With Hemophilia A or B Without Inhibitors Receiving Marstacimab in the BASIS Trial
Kim HK, Taylor CT, McDonald R, Sun P, Gould T, Palladino A
EAHAD 2025 - 欧洲血友病及相关疾病协会年会 2025 | 罕见病 | 血友病 | 友瑞宁
会议壁报
Indirect Treatment Comparison of Marstacimab versus Emicizumab in Haemophilia A
Sohn A, Gould T, Cappelleri J, Ines M, Wang Y, Nevo A, Jin H, Uyei J, Lindsley K, Boyne DJ
EAHAD 2025 - 欧洲血友病及相关疾病协会年会 2025 | 罕见病 | 血友病 | 友瑞宁
口头报告
Long-Term Efficacy of Marstacimab in Adults and Adolescents With Severe Hemophilia A or B Without Inhibitors Who Completed the BASIS Trial
Matino D, Sun P, Gould T, Taylor CT, McComb B, Wilcox L, Kazani S, Mefyod E, Biondo F, Palladino A.
EAHAD 2025 - 欧洲血友病及相关疾病协会年会 2025 | 罕见病 | 血友病 | 友瑞宁